Table: Pharmarise Holdings - 6-MTH group results
Dec 25 (Reuters)-
Pharmarise Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2025 Nov 30, 2024 May 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 33.60 30.54 66.80
(+10.0 pct) (+13.3 pct) (+5.2 pct)
Operating 399 mln 100 mln 1.12
(+296.3 pct) (-85.8 pct) (+282.2 pct)
Recurring 328 mln 29 mln 941 mln
(-95.8 pct) (+587.3 pct)
Net 111 mln loss 113 mln 266 mln
EPS 9.75 yen loss 10.09 yen 23.45 yen
EPS Diluted 9.37 yen
Ann Div 14.00 yen 14.00 yen
-Q2 div NIL NIL
-Q4 div 14.00 yen 14.00 yen
NOTE - Pharmarise Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T